30.93
-0.27(-0.87%)
Currency In USD
Address
100 Technology Center Drive
Stoughton, MA 02072
United States of America
Phone
781 713 3699
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
197
First IPO Date
May 07, 2015
| Name | Title | Pay | Year Born |
| Mr. Vikram Karnani | Chief Executive Officer, President & Director | 0 | 1975 |
| Mr. Michael Thomas Heffernan B.S. Pharm, R.Ph. | Co-Founder & Chairman | 110,000 | 1964 |
| Dr. Thomas B. Smith FAAFP, M.D. | Executive Vice President & Chief Medical Officer | 693,271 | 1961 |
| Mr. Scott Dreyer | Executive Vice President & Chief Commercial Officer | 693,539 | 1972 |
| Ms. Colleen Tupper | Executive Vice President & Chief Financial Officer | 782,645 | 1976 |
| Ms. Shirley R. Kuhlmann J.D. | Executive Vice President, General Counsel, Chief Administrative Officer & Secretary | 788,451 | 1984 |
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ER for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment. The company was formerly known as Collegium Pharmaceuticals, Inc. and changed its name to Collegium Pharmaceutical, Inc. in October 2003. Collegium Pharmaceutical, Inc. was incorporated in 2002 and is headquartered in Stoughton, Massachusetts.